Visit CURE at http://curenet.org and BioBus Educational Programs at http://ctbiobus.org

December 2007

 
A Nov 25 article in the NY Times calls Connecticut "Stem Cell Central." The work of UConn's David Rowe and Ren-He Xu, and Yale's Haifan Lin and Michael Snyder, is noted.   more
Events Column
2/7  Alternative Products and Green Chemistry: Challenges and Opportunities of the New Global Marketplace. Northeast Utilities Conference Center, Berlin, CT. more
2/12  3:00 pm - 6:00 pm. CURE and Yale OCR Present: Rib-X. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT.  Reception and networking to follow. Watch for details.
3/19  3:00 pm - 6:00 pm. CURE and Yale OCR Present: Optherion. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT.  Reception and networking to follow. more
3/26  Connecticut Innovations Annual Technology Celebration. The Aqua Turf Club, Southington, CT. more
4/11  8:00 am - 6:30 pm. Healthcare 2008 at the Yale School of Management. "Whose Healthcare is it Anyway? Understanding the Patient as a Consumer." Omni Hotel, New Haven, CT. more
4/16  3:30 pm - 6:00 pm. CURE and Yale OCR Present: The Next Big Idea - Creating a New Venture. A Special BioHaven Entrepreneurship Panel with Roger Longman of Windhover Publications. Reception and networking to follow. Anlyan Center, Congress Avenue, New Haven, CT. more
4/23  3:00 pm - 6:00 pm. CURE and Yale OCR Present: Vidus Ocular. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT.  Reception and networking to follow. more
Stem Cell Breakthroughs Make the News
From the desk of Paul Pescatello, President and CEO of CURE
Last month I wrote that Connecticut’s wise decision to embrace stem cell research was continuing to pay dividends. In the past few weeks, breaking news attests even further to the wisdom of that decision. To begin with, Haifan Lin and his stem cell center at Yale have succeeded in attracting another of the world's leading bioscientists to our state. Meanwhile, those following stem cell research were fascinated to read of experiments that point towards a promising alternative route to generating stem cells.
For the full story
BioRelix & Vascular Insights Launch BioHaven Series
The Yale BioHaven Entrepreneurship Series, presented by CURE and Yale OCR,  launched its 2007-2008 schedule with presentations by two local Yale spin-outs: BioRelix, which is developing antibiotics that target microbial RNA, and Vascular Insights, which will market a new device for treating varicose vein disease.
For the full story
CURE Member News Digest
 454 Life Sciences announces publication of over 100 studies Achillion reports on 3Q progress
 Alexion named winner of CURE Award of Excellence
 Bayer HealthCare reports Nexavar® approval
 Boehringer Ingelheim named top employer
 Bristol-Myers Squibb reports AVALIDE® progress
 Cara Therapeutics marks Shelton opening
 Connecticut Innovations names board members
 CuraGen comments on 3Q position
 Genomas reports pain research
 GlaxoSmithKline changes Avandia® label
 Hartford Hospital gets organ donation recognition
 HistoRx to use funding for AQUA® platform
 Invitrogen benefits from defense bill
 Ipsogen announces mutation tool kit
 Johnson & Johnson reports ZYRTEC® approval
 MannKind continues with inhalable insulin
 NanoViricides reports rabies progress
 Neurogen foresees advances in 4Q
 Pfizer to acquire Coley Pharmaceutical Group
 PhRMA reports on fight against staph infections
 Discovery magazine cites Protein Sciences Corporation vaccine
 Rib-X to present at Feb 12 BioHaven
 VaxInnate gains from defense bill
 Vion confirms Cloretazine® goals
 Winstanley buys 25 Science Park
 UConn names professor to BI endowed chair
 Yale gets funding for cancer center

For the full story
 
 
Copyright © 2008 Connecticut United for Research Excellence. All rights reserved.
Visit CURE at http://curenet.org and BioBus Educational Programs at http://ctbiobus.org
Newsletter developed and edited by
HarveyMalis Communications LLC, Guilford, Conn.